相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carfilzomib: A cause of drug associated thrombotic microangiopathy
Ibrahim Qaqish et al.
TRANSFUSION AND APHERESIS SCIENCE (2016)
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin
Jessica A. Reese et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma
Kah-Lok Chan et al.
LEUKEMIA & LYMPHOMA (2015)
Drug-induced thrombotic microangiopathy: a systematic review of published reports
Zayd L. Al-Nouri et al.
BLOOD (2015)
Carfilzomib Associated Thrombotic Microangiopathy Initially Treated With Therapeutic Plasma Exchange
Matthew R. Sullivan et al.
JOURNAL OF CLINICAL APHERESIS (2015)
Thrombotic microangiopathy associated with proteasome inhibitors
Ahad Lodhi et al.
CLINICAL KIDNEY JOURNAL (2015)
Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma
Hubert Yao et al.
CLINICAL NEPHROLOGY (2014)
Syndromes of Thrombotic Microangiopathy
James N. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Anti-VEGF Cancer Therapy in Nephrology Practice
Hassan Izzedine
INTERNATIONAL JOURNAL OF NEPHROLOGY (2014)
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
David Siegel et al.
HAEMATOLOGICA (2013)
Thrombotic thrombocytopenic purpura as initial and major presentation of multiple myeloma
Xiang Xiao et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Aphase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma
David S. Siegel et al.
BLOOD (2012)
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib
Ravi Vij et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib
H. Moore et al.
INTERNAL MEDICINE JOURNAL (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma
Rena Morita et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gemcitabine-associated thrombotic microangiopathy
BD Humphreys et al.
CANCER (2004)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes
K Kojouri et al.
ANNALS OF INTERNAL MEDICINE (2001)
Cyclosporine and tacrolimus-associated thrombotic microangiopathy
PTT Pham et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Thrombotic thrombocytopenic purpura associated with clopidogrel.
CL Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
